Cassava Sciences Inc (NASDAQ: SAVA) on Monday, plunged -3.53% from the previous trading day, before settling in for the closing price of $2.83. Within the past 52 weeks, SAVA’s price has moved between $2.23 and $42.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 62.79%. With a float of $41.80 million, this company’s outstanding shares have now reached $47.98 million.
In an organization with 29 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 58.82%, operating margin of -5985.86%, and the pretax margin is -752.3%.
Cassava Sciences Inc (SAVA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cassava Sciences Inc is 13.11%, while institutional ownership is 29.70%. The most recent insider transaction that took place on Nov 29 ’24, was worth 15,480. In this transaction Chief Medical Officer of this company sold 4,000 shares at a rate of $3.87, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 29 ’24, when Company’s Chief Financial Officer sold 59,800 for $3.86, making the entire transaction worth $230,828. This insider now owns 11,500 shares in total.
Cassava Sciences Inc (SAVA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 62.79% per share during the next fiscal year.
Cassava Sciences Inc (NASDAQ: SAVA) Trading Performance Indicators
Cassava Sciences Inc (SAVA) is currently performing well based on its current performance indicators. A quick ratio of 3.55 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.37, a number that is poised to hit -0.58 in the next quarter and is forecasted to reach -0.43 in one year’s time.
Technical Analysis of Cassava Sciences Inc (SAVA)
Let’s dig in a bit further. During the last 5-days, its volume was 3.41 million. That was inferior than the volume of 4.16 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 57.69%. Additionally, its Average True Range was 0.66.
During the past 100 days, Cassava Sciences Inc’s (SAVA) raw stochastic average was set at 1.57%, which indicates a significant decrease from 52.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.74% in the past 14 days, which was lower than the 300.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.44, while its 200-day Moving Average is $19.93. However, in the short run, Cassava Sciences Inc’s stock first resistance to watch stands at $2.82. Second resistance stands at $2.90. The third major resistance level sits at $3.03. If the price goes on to break the first support level at $2.60, it is likely to go to the next support level at $2.47. Assuming the price breaks the second support level, the third support level stands at $2.39.
Cassava Sciences Inc (NASDAQ: SAVA) Key Stats
Market capitalization of the company is 131.34 million based on 48,110K outstanding shares. Right now, sales total 0 K and income totals -97,220 K. The company made 0 K in profit during its latest quarter, and -27,940 K in sales during its previous quarter.
